Our findings also indicate that IFNα and CXCL10 recruit and activate CD8+ T cells toward the tumor cells (Fig. 6A–C), potentially transforming “cold tumors” into “hot tumors” that are more responsive to immunotherapy (Fig. 8). The gene discussed is CXCL10; the disease is neoplasm.